98TH GENERAL ASSEMBLY
State of Illinois
2013 and 2014
SB3275

 

Introduced 2/14/2014, by Sen. Kirk W. Dillard

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/204  from Ch. 56 1/2, par. 1204

    Amends the Illinois Controlled Substances Act. Adds 25I-NBOMe to the list of Schedule I controlled substances.


LRB098 12899 RLC 47399 b

CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY

 

 

A BILL FOR

 

SB3275LRB098 12899 RLC 47399 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 204 as follows:
 
6    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
7    Sec. 204. (a) The controlled substances listed in this
8Section are included in Schedule I.
9    (b) Unless specifically excepted or unless listed in
10another schedule, any of the following opiates, including their
11isomers, esters, ethers, salts, and salts of isomers, esters,
12and ethers, whenever the existence of such isomers, esters,
13ethers and salts is possible within the specific chemical
14designation:
15        (1) Acetylmethadol;
16        (1.1) Acetyl-alpha-methylfentanyl
17    (N-[1-(1-methyl-2-phenethyl)-
18    4-piperidinyl]-N-phenylacetamide);
19        (2) Allylprodine;
20        (3) Alphacetylmethadol, except
21    levo-alphacetylmethadol (also known as levo-alpha-
22    acetylmethadol, levomethadyl acetate, or LAAM);
23        (4) Alphameprodine;

 

 

SB3275- 2 -LRB098 12899 RLC 47399 b

1        (5) Alphamethadol;
2        (6) Alpha-methylfentanyl
3    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
4    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
5    propanilido) piperidine;
6        (6.1) Alpha-methylthiofentanyl
7    (N-[1-methyl-2-(2-thienyl)ethyl-
8    4-piperidinyl]-N-phenylpropanamide);
9        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
10        (7.1) PEPAP
11    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
12        (8) Benzethidine;
13        (9) Betacetylmethadol;
14        (9.1) Beta-hydroxyfentanyl
15    (N-[1-(2-hydroxy-2-phenethyl)-
16    4-piperidinyl]-N-phenylpropanamide);
17        (10) Betameprodine;
18        (11) Betamethadol;
19        (12) Betaprodine;
20        (13) Clonitazene;
21        (14) Dextromoramide;
22        (15) Diampromide;
23        (16) Diethylthiambutene;
24        (17) Difenoxin;
25        (18) Dimenoxadol;
26        (19) Dimepheptanol;

 

 

SB3275- 3 -LRB098 12899 RLC 47399 b

1        (20) Dimethylthiambutene;
2        (21) Dioxaphetylbutyrate;
3        (22) Dipipanone;
4        (23) Ethylmethylthiambutene;
5        (24) Etonitazene;
6        (25) Etoxeridine;
7        (26) Furethidine;
8        (27) Hydroxpethidine;
9        (28) Ketobemidone;
10        (29) Levomoramide;
11        (30) Levophenacylmorphan;
12        (31) 3-Methylfentanyl
13    (N-[3-methyl-1-(2-phenylethyl)-
14    4-piperidyl]-N-phenylpropanamide);
15        (31.1) 3-Methylthiofentanyl
16    (N-[(3-methyl-1-(2-thienyl)ethyl-
17    4-piperidinyl]-N-phenylpropanamide);
18        (32) Morpheridine;
19        (33) Noracymethadol;
20        (34) Norlevorphanol;
21        (35) Normethadone;
22        (36) Norpipanone;
23        (36.1) Para-fluorofentanyl
24    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
25    4-piperidinyl]propanamide);
26        (37) Phenadoxone;

 

 

SB3275- 4 -LRB098 12899 RLC 47399 b

1        (38) Phenampromide;
2        (39) Phenomorphan;
3        (40) Phenoperidine;
4        (41) Piritramide;
5        (42) Proheptazine;
6        (43) Properidine;
7        (44) Propiram;
8        (45) Racemoramide;
9        (45.1) Thiofentanyl
10    (N-phenyl-N-[1-(2-thienyl)ethyl-
11    4-piperidinyl]-propanamide);
12        (46) Tilidine;
13        (47) Trimeperidine;
14        (48) Beta-hydroxy-3-methylfentanyl (other name:
15    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
16    N-phenylpropanamide).
17    (c) Unless specifically excepted or unless listed in
18another schedule, any of the following opium derivatives, its
19salts, isomers and salts of isomers, whenever the existence of
20such salts, isomers and salts of isomers is possible within the
21specific chemical designation:
22        (1) Acetorphine;
23        (2) Acetyldihydrocodeine;
24        (3) Benzylmorphine;
25        (4) Codeine methylbromide;
26        (5) Codeine-N-Oxide;

 

 

SB3275- 5 -LRB098 12899 RLC 47399 b

1        (6) Cyprenorphine;
2        (7) Desomorphine;
3        (8) Diacetyldihydromorphine (Dihydroheroin);
4        (9) Dihydromorphine;
5        (10) Drotebanol;
6        (11) Etorphine (except hydrochloride salt);
7        (12) Heroin;
8        (13) Hydromorphinol;
9        (14) Methyldesorphine;
10        (15) Methyldihydromorphine;
11        (16) Morphine methylbromide;
12        (17) Morphine methylsulfonate;
13        (18) Morphine-N-Oxide;
14        (19) Myrophine;
15        (20) Nicocodeine;
16        (21) Nicomorphine;
17        (22) Normorphine;
18        (23) Pholcodine;
19        (24) Thebacon.
20    (d) Unless specifically excepted or unless listed in
21another schedule, any material, compound, mixture, or
22preparation which contains any quantity of the following
23hallucinogenic substances, or which contains any of its salts,
24isomers and salts of isomers, whenever the existence of such
25salts, isomers, and salts of isomers is possible within the
26specific chemical designation (for the purposes of this

 

 

SB3275- 6 -LRB098 12899 RLC 47399 b

1paragraph only, the term "isomer" includes the optical,
2position and geometric isomers):
3        (1) 3,4-methylenedioxyamphetamine
4    (alpha-methyl,3,4-methylenedioxyphenethylamine,
5    methylenedioxyamphetamine, MDA);
6        (1.1) Alpha-ethyltryptamine
7    (some trade or other names: etryptamine;
8    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
9    3-(2-aminobutyl)indole; a-ET; and AET);
10        (2) 3,4-methylenedioxymethamphetamine (MDMA);
11        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
12    (also known as: N-ethyl-alpha-methyl-
13    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
14    and MDEA);
15        (2.2) N-Benzylpiperazine (BZP);
16        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
17        (4) 3,4,5-trimethoxyamphetamine (TMA);
18        (5) (Blank);
19        (6) Diethyltryptamine (DET);
20        (7) Dimethyltryptamine (DMT);
21        (7.1) 5-Methoxy-diallyltryptamine;
22        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
23        (9) Ibogaine  (some trade and other names:
24    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
25    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
26    indole; Tabernanthe iboga);

 

 

SB3275- 7 -LRB098 12899 RLC 47399 b

1        (10) Lysergic acid diethylamide;
2        (10.1) Salvinorin A;
3        (10.5) Salvia divinorum (meaning all parts of the plant
4    presently classified botanically as Salvia divinorum,
5    whether growing or not, the seeds thereof, any extract from
6    any part of that plant, and every compound, manufacture,
7    salts, isomers, and salts of isomers whenever the existence
8    of such salts, isomers, and salts of isomers is possible
9    within the specific chemical designation, derivative,
10    mixture, or preparation of that plant, its seeds or
11    extracts);
12        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
13        (12) Peyote (meaning all parts of the plant presently
14    classified botanically as Lophophora williamsii Lemaire,
15    whether growing or not, the seeds thereof, any extract from
16    any part of that plant, and every compound, manufacture,
17    salts, derivative, mixture, or preparation of that plant,
18    its seeds or extracts);
19        (13) N-ethyl-3-piperidyl benzilate (JB 318);
20        (14) N-methyl-3-piperidyl benzilate;
21        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
22    (also known as N-hydroxy-alpha-methyl-
23    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
24        (15) Parahexyl; some trade or other names:
25    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
26    dibenzo (b,d) pyran; Synhexyl;

 

 

SB3275- 8 -LRB098 12899 RLC 47399 b

1        (16) Psilocybin;
2        (17) Psilocyn;
3        (18) Alpha-methyltryptamine (AMT);
4        (19) 2,5-dimethoxyamphetamine
5    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
6        (20) 4-bromo-2,5-dimethoxyamphetamine
7    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
8    4-bromo-2,5-DMA);
9        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
10    Some trade or other names: 2-(4-bromo-
11    2,5-dimethoxyphenyl)-1-aminoethane;
12    alpha-desmethyl DOB, 2CB, Nexus;
13        (21) 4-methoxyamphetamine
14    (4-methoxy-alpha-methylphenethylamine;
15    paramethoxyamphetamine; PMA);
16        (22) (Blank);
17        (23) Ethylamine analog of phencyclidine.
18    Some trade or other names:
19    N-ethyl-1-phenylcyclohexylamine,
20    (1-phenylcyclohexyl) ethylamine,
21    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
22        (24) Pyrrolidine analog of phencyclidine. Some trade
23    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
24    PHP;
25        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
26        (26) 2,5-dimethoxy-4-ethylamphetamine

 

 

SB3275- 9 -LRB098 12899 RLC 47399 b

1    (another name: DOET);
2        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
3    (another name: TCPy);
4        (28) (Blank);
5        (29) Thiophene analog of phencyclidine (some trade
6    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
7    2-thienyl analog of phencyclidine; TPCP; TCP);
8        (30) Bufotenine (some trade or other names:
9    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
10    3-(2-dimethylaminoethyl)-5-indolol;
11    5-hydroxy-N,N-dimethyltryptamine;
12    N,N-dimethylserotonin; mappine);
13        (31)  1-Pentyl-3-(1-naphthoyl)indole 
14    Some trade or other names: JWH-018; 
15        (32) 1-Butyl-3-(1-naphthoyl)indole 
16    Some trade or other names: JWH-073;  
17        (33) 1-[(5-fluoropentyl)-1H-indol-3-yl]- 
18    (2-iodophenyl)methanone 
19    Some trade or other names: AM-694;
20        (34) 2-[(1R,3S)-3-hydroxycyclohexyl]-5-
21    (2-methyloctan-2-yl)phenol 
22    Some trade or other names: CP 47,497 
23    and its C6, C8 and C9 homologs;
24        (34.5)  2-[(1R,3S)-3-hydroxycyclohexyl]-5- 
25    (2-methyloctan-2-yl)phenol), where side chain n=5;  
26    and homologues where side chain n=4, 6, or 7;  Some  

 

 

SB3275- 10 -LRB098 12899 RLC 47399 b

1    trade or other names: CP 47,497; 
2        (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
3    (2-methyloctan-2-yl)-6a,7, 
4    10,10a-tetrahydrobenzo[c]chromen-1-ol
5    Some trade or other names: HU-210; 
6        (35.5)  (6aS,10aS)-9-(hydroxymethyl)-6,6- 
7    dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 
8    tetrahydrobenzo[c]chromen-1-ol, its isomers,  
9    salts, and salts of isomers; Some trade or other  
10    names: HU-210, Dexanabinol; 
11        (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
12    6,6-dimethyl-3-(2-methyloctan-2-yl)- 
13    6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
14    Some trade or other names: HU-211;
15        (37) (2-methyl-1-propyl-1H-indol-
16    3-yl)-1-naphthalenyl-methanone 
17    Some trade or other names: JWH-015;
18        (38) 4-methoxynaphthalen-1-yl-
19    (1-pentylindol-3-yl)methanone 
20    Some trade or other names: JWH-081;
21        (39) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole
22    Some trade or other names: JWH-122;
23        (40) 2-(2-methylphenyl)-1-(1-pentyl-
24    1H-indol-3-yl)-ethanone 
25    Some trade or other names: JWH-251;
26        (41) 1-(2-cyclohexylethyl)-3- 

 

 

SB3275- 11 -LRB098 12899 RLC 47399 b

1    (2-methoxyphenylacetyl)indole 
2    Some trade or other names: RCS-8, BTW-8 and SR-18; 
3        (42)  Any compound structurally derived from 
4    3-(1-naphthoyl)indole or 1H-indol-3-yl- 
5    (1-naphthyl)methane by substitution at the 
6    nitrogen atom of the indole ring by alkyl, haloalkyl, 
7    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
8    2-(4-morpholinyl)ethyl whether or not further 
9    substituted in the indole ring to any extent, whether 
10    or not substituted in the naphthyl ring to any extent; 
11        (43)  Any compound structurally derived from 
12    3-(1-naphthoyl)pyrrole by substitution at the nitrogen 
13    atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, 
14    cycloalkylmethyl, cycloalkylethyl or 
15    2-(4-morpholinyl)ethyl, whether or not further 
16    substituted in the pyrrole ring to any extent, whether 
17    or not substituted in the naphthyl ring to any extent; 
18        (44)  Any compound structurally derived from 
19    1-(1-naphthylmethyl)indene by substitution 
20    at the 3-position of the indene ring by alkyl, haloalkyl, 
21    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
22    2-(4-morpholinyl)ethyl whether or not further 
23    substituted in the indene ring to any extent, whether 
24    or not substituted in the naphthyl ring to any extent; 
25        (45)  Any compound structurally derived from 
26    3-phenylacetylindole by substitution at the 

 

 

SB3275- 12 -LRB098 12899 RLC 47399 b

1    nitrogen atom of the indole ring with alkyl, haloalkyl, 
2    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
3    2-(4-morpholinyl)ethyl, whether or not further 
4    substituted in the indole ring to any extent, whether 
5    or not substituted in the phenyl ring to any extent; 
6        (46)  Any compound structurally derived from 
7    2-(3-hydroxycyclohexyl)phenol by substitution 
8    at the 5-position of the phenolic ring by alkyl, 
9    haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl 
10    or 2-(4-morpholinyl)ethyl, whether or not substituted 
11    in the cyclohexyl ring to any extent; 
12        (47)  3,4-Methylenedioxymethcathinone 
13    Some trade or other names: Methylone; 
14        (48)  3,4-Methyenedioxypyrovalerone 
15    Some trade or other names: MDPV; 
16        (49)  4-Methylmethcathinone 
17    Some trade or other names: Mephedrone; 
18        (50)  4-methoxymethcathinone; 
19        (51)  4-Fluoromethcathinone; 
20        (52)  3-Fluoromethcathinone; 
21        (53)  2,5-Dimethoxy-4-(n)-propylthio- 
22    phenethylamine; 
23        (54)  5-Methoxy-N,N-diisopropyltryptamine; 
24        (55) Pentedrone; . 
25        (56)  4-iodo-2,5-dimethoxy-N-((2-methoxy 
26    phenyl)methyl)-benzeneethanamine 

 

 

SB3275- 13 -LRB098 12899 RLC 47399 b

1    (trade or other name: 25I-NBOMe). 
2    (e) Unless specifically excepted or unless listed in
3another schedule, any material, compound, mixture, or
4preparation which contains any quantity of the following
5substances having a depressant effect on the central nervous
6system, including its salts, isomers, and salts of isomers
7whenever the existence of such salts, isomers, and salts of
8isomers is possible within the specific chemical designation:
9        (1) mecloqualone;
10        (2) methaqualone; and
11        (3) gamma hydroxybutyric acid.
12    (f) Unless specifically excepted or unless listed in
13another schedule, any material, compound, mixture, or
14preparation which contains any quantity of the following
15substances having a stimulant effect on the central nervous
16system, including its salts, isomers, and salts of isomers:
17        (1) Fenethylline;
18        (2) N-ethylamphetamine;
19        (3) Aminorex (some other names:
20    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
21    4-5-dihydro-5-phenyl-2-oxazolamine) and its
22    salts, optical isomers, and salts of optical isomers;
23        (4) Methcathinone (some other names:
24    2-methylamino-1-phenylpropan-1-one;
25    Ephedrone; 2-(methylamino)-propiophenone;
26    alpha-(methylamino)propiophenone; N-methylcathinone;

 

 

SB3275- 14 -LRB098 12899 RLC 47399 b

1    methycathinone; Monomethylpropion; UR 1431) and its
2    salts, optical isomers, and salts of optical isomers;
3        (5) Cathinone (some trade or other names:
4    2-aminopropiophenone; alpha-aminopropiophenone;
5    2-amino-1-phenyl-propanone; norephedrone);
6        (6) N,N-dimethylamphetamine (also known as:
7    N,N-alpha-trimethyl-benzeneethanamine;
8    N,N-alpha-trimethylphenethylamine);
9        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
10    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
11        (8) 3,4-Methylenedioxypyrovalerone (MDPV).
12    (g) Temporary listing of substances subject to emergency
13scheduling. Any material, compound, mixture, or preparation
14that contains any quantity of the following substances:
15        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
16    (benzylfentanyl), its optical isomers, isomers, salts,
17    and salts of isomers;
18        (2) N-[1(2-thienyl)
19   methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
20   its optical isomers, salts, and salts of isomers.
21(Source: P.A. 96-347, eff. 1-1-10; 96-1285, eff. 1-1-11;
2297-192, eff. 7-22-11; 97-193, eff. 1-1-12; 97-194, eff.
237-22-11; 97-334, eff. 1-1-12; 97-813, eff. 7-13-12; 97-872,
24eff. 7-31-12.)